U.S. markets open in 9 hours 26 minutes
  • S&P Futures

    4,124.75
    +17.75 (+0.43%)
     
  • Dow Futures

    34,054.00
    +116.00 (+0.34%)
     
  • Nasdaq Futures

    13,180.75
    +80.50 (+0.61%)
     
  • Russell 2000 Futures

    2,178.30
    +9.70 (+0.45%)
     
  • Crude Oil

    63.62
    -0.20 (-0.31%)
     
  • Gold

    1,822.10
    -1.90 (-0.10%)
     
  • Silver

    27.05
    -0.01 (-0.05%)
     
  • EUR/USD

    1.2090
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.6680
    -0.0270 (-1.59%)
     
  • Vix

    23.13
    -4.46 (-16.17%)
     
  • GBP/USD

    1.4049
    -0.0003 (-0.02%)
     
  • USD/JPY

    109.5520
    +0.1180 (+0.11%)
     
  • BTC-USD

    49,328.01
    -1,484.19 (-2.92%)
     
  • CMC Crypto 200

    1,355.92
    -31.99 (-2.30%)
     
  • FTSE 100

    6,963.33
    -41.30 (-0.59%)
     
  • Nikkei 225

    27,978.57
    +530.56 (+1.93%)
     

Why Concert Pharmaceuticals Stock Cratered Today

Keith Speights, The Motley Fool
·2 min read
Why Concert Pharmaceuticals Stock Cratered Today
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Concert Pharmaceuticals (NASDAQ: CNCE) were cratering 28.9% as of 3:26 p.m. EST on Monday. The steep decline came after the company announced that experimental drug CTP-692 had failed to meet the primary and secondary endpoints in a phase 2 study as an adjunctive treatment for schizophrenia.